SHOPPER

GLP-1 & Injectable Medications

The GLP-1 and injectable medications (such as Ozempic) usage and attitudes study is for companies seeking a strategic view of the impact of GLP-1 medications.

Now available across US and international markets!

 

To learn more about the study, fill out the form below


Benefitting from Change: GLP-1

Bringing clarity and insight to map the impact of pharma innovation on food, beverage & beyond

 

Picture1-Nov-04-2024-01-44-30-4747-PM


Understanding GLP-1 users

Who, when, and why do they use medications and what is their journey

What are users striving for and how are they adopting healthy lifestyles?

Picture2-4


Impact on consumption

What impact GLP-1s have on what they buy, eat and how they are choosing

How much do GLP-1s change shopping patterns plus where and what they put in/on their bodies?

Picture3-3


Impact beyond food

Beyond consumption, what other parts of their lives are being shifted/reinvented

From work to fitness to travel, how can we support their renewed approach?


 

Kantar's global syndicated GLP-1 studies

 

 

GLP

GLP-1 Syndicated Study - US 

Current and lapsed GLP-1 users’ attitudes and usage patterns: who are they?  What do they consume?  How do they shop? What is their outlook?

What you'll get:

  • 100+ page report each quarter
  • Questionnaire and data tables
  • Quarterly trends and news

 

glp1-2

GLP-1 Syndicated Study - International

The GLP-1 study will expand from a single geography (US) to multiple countries outside the US.

Geographies and Output

  • Over a dozen markets possible, market selection of your choosing
  • One-time fielding, you'll get
    • 50+ pages of reporting
    • Comparison across US & International
    • Standalone report for each country purchased
  • Complete data file

 

 

 

A holistic look into GLP-1 and how shoppers are responding to the latest pharma innovation.

Data will be fielded throughout the year with insights available quarterly.

WHAT YOU WILL LEARN

HOW YOU USE IT

THE DETAILS YOU NEED

  • Who uses GLP-1 medications? How is their lifestyle evolving?

  • What is the impact on the Food and Beverage industries?
  • How much to GLP-1s change shopping patterns as far as where and what they eat?

  • Comprehend this rapidly evolving space by understanding the demographics and attitudes of users

  • Understand user' needs for products, innovation, and experience at retail

  • Get prepared for major shifts due to the rapid adoption of this new drug

Robust sample: 500 shoppers​​

75+ page report with actionable insights​

Fully sliceable complete databook for each wave

Customize the study to meet your needs: add search analytics, future-planning, and GTM scenarios

Become a VIP to adapt the study to fit your business needs

With a VIP partnership, you can make sure the study will yield answers to your burning questions about shoppers and how they are reacting to and using GLP-1 medications.

  • Influence and guide the retailer list 
  • Request specific category coverage
  • Influence up to 5 question topics

Contact us for more information at KantarShopper@kantar.com



 

EXPERT SPOTLIGHT

Kantar's Retail, Sales,
and Shopper Experts

Answering your most pressing questions related to shopper commerce.
Leigh_20
Leigh O'Donnell
Head of Shopper and Category Insights & Solutions
brettwhitfield.m_KANTAR_039
Mary Brett Whitfield
Senior Vice President Shopper Insights
Craig_Julie_Kantar-1
Julie Craig
Vice President Shopper Insights
Looking for insights?

Take a look at content catered to you.

Retail Sound Bites

The Kantar Sound Bites podcast provides a provocative view of global retail trends, category leadership, business issues, and other shopper and retail related news. 

Subscribe to the Podcast
podcast equipment microphone

Breakthrough Insights 2024

Kantar's inaugural report bring you our expert point of view and data on our six key retail themes of 2024. 

Download the Report
cover2 (1)

PoweRanking® 2023

Kantar’s annual industry benchmarking report identifies retailers and suppliers that set the standard of performance, ranked by their trading partners.  

Download the Report
Artboard 1_3@3x-1